|
|
40
|
|
|
5641BS
|
|
|
C ZID 1G INJ (EMC/COL) CEFTAZIDIME
|
|
|
CEFTAZIDIME
|
|
|
C ZID
|
|
|
1G VIAL
|
|
|
B
|
|
|
4.08
|
|
|
4.08
|
|
|
1G
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
EMC
|
|
|
EMCURE PHARMACEUTICALS LTD
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
Yes
|
|
|
08120612
|
|
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
|
IV
|
|
|
6
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|